Skip to content

Prospective observational study on the impact of vaccination against COVID-19 among National Cancer Center staff.

Prospective observational study on the impact of vaccination against COVID-19 among National Cancer Center staff. - Prospective observational study on the impact of vaccination against COVID-19 among National Cancer Center staff.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049430
Enrollment
200
Registered
2022-11-04
Start date
2021-06-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

None listed

Sponsors

National cancer center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) an employee of the National Cancer Center 2) Subjects who have given written consent for this study 3) The subject is scheduled to receive the COVID19 or is within 12 months of receiving the second (or last) dose of the vaccine.

Exclusion criteria

Exclusion criteria: Subjects who are determined not to be appropriate subjects for this study by the Principal Investigator or the Research Office

Design outcomes

Primary

MeasureTime frame
SARS-CoV-2 antibody positivity after 2 doses of vaccine

Countries

Japan

Contacts

Public ContactYuki Katsuya

National Cancer Center Hospital Department of experimental development

ykatsuya@ncc.go.jp0335422511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026